International Health Management Associates, Schaumburg, Illinois, United States of America.
AstraZeneca Pharmaceuticals, Waltham, Massachusetts, United States of America.
PLoS One. 2018 Apr 2;13(4):e0195281. doi: 10.1371/journal.pone.0195281. eCollection 2018.
A set of 908 clinically derived colistin-resistant Enterobacteriaeae isolates collected worldwide in 2014-2016 were screened for the presence of the plasmid-borne mcr-1, mcr-2, mcr-3, mcr-4 and mcr-5 genes. In total 3.2% (29/908) of the collection were positive for mcr, including 27 Escherichia coli, 1 Klebsiella pneumoniae and 1 Enterobacter cloacae. Twenty-four isolates possessed genes from the mcr-1 family, including the original mcr-1 (n = 22), as well as mcr-1.2 (n = 1) and mcr-1.5 (n = 1), which each differ from mcr-1 by encoding single amino acid variations. Genes from the mcr-3 family were found in isolates from Thailand, including mcr-3.1 (n = 3) and mcr-3.2 (n = 1). An E. coli isolated from a patient with a urinary tract infection in Colombia contained the recently discovered mcr-5. The full colistin-resistant collection was tested against a panel of antimicrobial agents with ceftazidime-avibactam and tigecycline exhibiting the highest activity.
一组 908 株 2014-2016 年全球临床分离的粘菌素耐药肠杆菌科细菌进行了筛选,以检测质粒携带的 mcr-1、mcr-2、mcr-3、mcr-4 和 mcr-5 基因。共发现 3.2%(29/908)的分离株 mcr 阳性,包括 27 株大肠埃希菌、1 株肺炎克雷伯菌和 1 株阴沟肠杆菌。24 株分离株携带 mcr-1 家族基因,包括原始 mcr-1(n=22),以及 mcr-1.2(n=1)和 mcr-1.5(n=1),它们在编码单个氨基酸变异方面与 mcr-1 不同。来自泰国的分离株携带 mcr-3 家族基因,包括 mcr-3.1(n=3)和 mcr-3.2(n=1)。哥伦比亚一名尿路感染患者的分离株含有最近发现的 mcr-5。整个粘菌素耐药分离株被测试了一组抗菌药物,头孢他啶-阿维巴坦和替加环素显示出最高的活性。